AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2018
Aug 17, 2018
34395_dirs_2018-08-17_1b92d09f-79a3-4757-b92a-93871394c6fe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2018-08-16
Reporting Person: Rootsaert Rodney Gerard (Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-16 | Common Stock | P | 5000 | $1.91 | Acquired | 9828 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1007718 | Indirect |
Footnotes
F1: The shares of Common Stock are held directly by Concord International, Inc. Mr. Rootsaert is a controlling director of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.
More from VOLITIONRX LTD
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 1
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31